J Am Pharm Assoc (2003). 2020 Nov-Dec;60(6):e246-e251. doi: 10.1016/j.japh.2020.08.003. Epub 2020 Aug 26.
This study aimed to determine the impact of a pharmacist-led antimicrobial stewardship program (ASP) intervention on outpatient antibiotic prescribing for upper respiratory tract infections (URIs) and urinary tract infections (UTIs) in a primary care office. The primary outcome of this study was to characterize antibiotic prescribing over time. Secondary outcomes included describing ambulatory care pharmacist (ACP) workload and types of feedback given.
A retrospective pilot study was conducted within a primary care office. The office included a 0.6 full-time equivalent ACP and is part of a health system supported by a pharmacist and a physician co-led ASP. Education and guidelines were provided by the ACP and ASP leads before the intervention period August 2017-February 2018. The ACP provided bi-weekly audit of all URI and UTI prescriptions and written feedback to prescribers.
During the 7-month intervention period, 1107 prescriptions were audited by the ACP, 825 URI and 282 UTI. The most common reasons for feedback included inappropriate agent (26.3%) or prolonged duration of therapy (24.3%). Guideline-concordant agent prescribed for a UTI increased from 20% at baseline to a median of 69.2%, whereas duration increased from 55% to 70.4%. Guideline-concordant agent prescribed for a URI increased from 43.3% to 86.8%, whereas the median duration of therapy decreased from 10 to 7 days.
An ACP-led ASP intervention within a primary care office incorporating audit and feedback improved antibiotic prescribing for URIs and UTIs, including prescribing antibiotics when indicated, guideline-concordant antibiotic selection, and duration of therapy. Pharmacists practicing in ambulatory care settings may serve a vital role in leading successful outpatient ASP interventions.
本研究旨在确定药剂师主导的抗菌药物管理计划(ASP)干预对初级保健诊所门诊呼吸道感染(URIs)和尿路感染(UTIs)处方的影响。本研究的主要结果是随时间推移描述抗生素的使用情况。次要结果包括描述门诊护理药剂师(ACP)的工作量和提供的反馈类型。
在初级保健诊所内进行回顾性试点研究。该诊所包括 0.6 名全职等效 ACP,是由药剂师和医师共同领导的 ASP 支持的医疗系统的一部分。在干预期(2017 年 8 月至 2018 年 2 月)之前,由 ACP 和 ASP 领导提供教育和指南。ACP 对所有 URI 和 UTI 处方进行双周审核,并向处方医生提供书面反馈。
在 7 个月的干预期间,共审核了 1107 份处方,其中 825 份为 URI,282 份为 UTI。反馈的最常见原因包括药物选择不当(26.3%)或治疗时间过长(24.3%)。对于 UTI,符合指南的药物的处方从基线时的 20%增加到中位数的 69.2%,而持续时间从 55%增加到 70.4%。对于 URI,符合指南的药物的处方从 43.3%增加到 86.8%,而治疗时间的中位数从 10 天减少到 7 天。
在初级保健诊所中,由 ACP 主导的 ASP 干预措施,包括审核和反馈,可改善 URIs 和 UTIs 的抗生素使用情况,包括在需要时开具抗生素、选择符合指南的抗生素以及治疗时间。在门诊护理环境中执业的药剂师可以在领导成功的门诊 ASP 干预方面发挥重要作用。